Results 291 to 300 of about 59,251 (307)

Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial

Circulation, 2019
David A Morrow, Eric J Velazquez, Adam D Devore   +2 more
exaly  

Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double‐blind, randomized comparison of two uptitration regimens

European Journal of Heart Failure, 2016
Michele Senni, John J V Mcmurray, Rolf Wachter   +2 more
exaly  

Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension

Hypertension, 2017
Kazuomi Kario
exaly  

Bisoprolol/Valsartan/Valsartan/hydrochlorothiazide

Reactions Weekly
openaire   +1 more source

Occurrence and fate of the angiotensin II receptor antagonist transformation product valsartan acid in the water cycle – A comparative study with selected β-blockers and the persistent anthropogenic wastewater indicators carbamazepine and acesulfame

Water Research, 2013
Karsten Nödler, Olav Hillebrand, Tobias Licha   +2 more
exaly  

Valsartan

Reactions Weekly, 2008
openaire   +1 more source

Valsartan

Reactions Weekly, 2010
openaire   +2 more sources

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF

Journal of the American College of Cardiology, 2019
Michael R Zile, Brian Lee Claggett, Milton Packer   +2 more
exaly  

Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study

European Journal of Heart Failure, 2019
Hélène Nougué, Théo Pezel, Mattia Arrigo   +2 more
exaly  

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study

Lancet, The, 2014
Michael A Weber, Jan Basile
exaly